Comprehensive Assessment of Genetic Sequence Variants in the Antioxidant ‘Master Regulator’ Nrf2 in Idiopathic Parkinson’s Disease

• Michael Todorovic,

  Affiliation Eskitis Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia

  ⨯
• Jeremy R. B. Newman,

  Affiliation Eskitis Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia

  ⨯
• Jianguo Shan,

  Affiliation Eskitis Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia

  ⨯
• Steven Bentley,

  Affiliation Eskitis Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia

  ⨯
• Stephen A. Wood,

  Affiliation Eskitis Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia

  ⨯
• Peter A. Silburn,

  Affiliation Asia-Pacific Centre for Neuromodulation, UQCCR, University of Queensland, Herston, Queensland, Australia

  ⨯
• George D. Mellick

  * E-mail: G.Mellick@griffith.edu.au

  Affiliations Eskitis Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia, Asia-Pacific Centre for Neuromodulation, UQCCR, University of Queensland, Herston, Queensland, Australia

  ⨯